$CTIX Recent Headlines Cellceutix Overvalued By 90-99%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX Recent Headlines

Cellceutix Overvalued By 90-99% 5:21 p.m. Jan. 2, 2015 - Seeking Alpha
CorMedix Update: Setting A New Standard For Catheter Care 7:07 a.m. Dec. 28, 2014 - Seeking Alpha
Cellceutix jumps on QIDP tag 1:23 p.m. Dec. 8, 2014 - Seeking Alpha
Cellceutix Brilacidin IND effective, Phase 2 to begin 9:31 a.m. Oct. 13, 2014 - Seeking Alpha
Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix 9:02 a.m. Sept. 25, 2014 - Seeking Alpha
Update: Cellceutix Calls Out To President Obama About Brilacidin 2:38 p.m. Sept. 21, 2014 - Seeking Alpha
10-K: CELLCEUTIX CORP 12:53 p.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol 2:06 a.m. Sept. 14, 2014 - Seeking Alpha
The Antibiotic Resistance Triple Threat 1:05 p.m. Sept. 4, 2014 - Seeking Alpha
Cellceutix completes enrollment in Brilacidin trial 8:45 a.m. Aug. 19, 2014 - Seeking Alpha
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 9:15 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 9:34 a.m. April 25, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 4:09 p.m. Feb. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin 9:31 a.m. Jan. 28, 2014 - Seeking Alpha
Cellceutix Corp.: A Biotech With High Risk But High Reward 3:17 p.m. Jan. 2, 2014 - Wall St. Cheat Sheet
Cellceutix: An Undiscovered Company Set To Rise In 2014 9:06 a.m. Dec. 16, 2013 - Seeking Alpha
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference 5:38 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: CELLCEUTIX CORP 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: CELLCEUTIX CORP 3:01 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)


Cellceutix Invites All to Attend Company's Live Webcast of Presentation at Biotech Showcase 2015 Today at 2:00 PM PT (5:00 PM ET) 7:01 a.m. Jan. 12, 2015 - Marketwired
Cellceutix Adds Dr. Daniel Jorgensen as Chief Medical Officer 7:00 a.m. Dec. 29, 2014 - Marketwired
Cellceutix Reports Positive Results of Brilacidin in Microbiological Intent-to-Treat Population in Phase 2b ABSSSI Trial; Additional Pharmacokinetic Information to Be Submitted 7:01 a.m. Dec. 22, 2014 - Marketwired
Cellceutix: Prurisol(TM) for Psoriasis -- FDA Agrees That Phase 2 Study May Begin 7:41 a.m. Dec. 10, 2014 - Marketwired
Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA 7:01 a.m. Dec. 8, 2014 - Marketwired
Cellceutix: December to Be Momentous Month in Company's History 7:02 a.m. Nov. 24, 2014 - Marketwired
These Medical Stocks Are Reaching A Fever Pitch Following Midterm Elections 9:54 a.m. Nov. 12, 2014 - ACCESSWIRE
Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014 7:01 a.m. Nov. 11, 2014 - Marketwired
Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders 6:00 a.m. Oct. 31, 2014 - Marketwired
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin 10:52 a.m. Oct. 23, 2014 - Marketwired
Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site for Phase 2 Clinical Trial of New Treatment for Oral Mucositis 8:02 a.m. Oct. 13, 2014 - Marketwired
Cellceutix Provides Update to Shareholders 11:30 a.m. Sept. 24, 2014 - Marketwire
Cellceutix to President Obama: We Have the Tools and Will Rise Up to the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a Serious Threat to Public Health 6:15 a.m. Sept. 19, 2014 - Marketwire
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis 2:01 p.m. Sept. 9, 2014 - Marketwire
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 10:17 a.m. Sept. 5, 2014 - Marketwire
Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting 6:01 a.m. Sept. 2, 2014 - Marketwire
Cellceutix Completes Enrollment in Phase 2b Clinical Trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 7:31 a.m. Aug. 19, 2014 - Marketwire
Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis 6:01 a.m. Aug. 11, 2014 - Marketwire
Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial 5:04 a.m. Aug. 8, 2014 - Marketwire
Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial for Acute Bacterial Skin and Skin Structure Infections Expected This Month 6:01 a.m. Aug. 4, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rodeo Dental Gears Up for National Growth Surge

Updated Category News Views 2

Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...

Continue Reading
Graphic Packaging Names Berardinelli as HR Executive

Updated Category News Views 5

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 0

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Doug Larson Takes Helm at Integra Pool Covers

Updated Category News Views 2

A Seasoned Pro Joins Integra Pool Covers Change is afoot over at Explore Industries. They just tapped Doug Larson to be the General Manager for their Integra Pool Covers division. Now, I've seen plenty of hiring announcements in my day, but this has got an interesting ring to it. With Doug on this ship, it's like bringing a wolf back to the wild. Larson's no stranger to...

Continue Reading
Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

Updated Category News Views 2

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

Continue Reading
USF Law Innovators: Leading AI Integration in Academics

Updated Category News Views 0

Revolutionizing Legal Academia with AI If there's one thing that's caught my eye in the realm of education, it's how some folks over at the University of San Francisco School of Law are shaking things up. These legal eagles aren't messing around with the usual, archaic ways of teaching the law. Nope, they've dove headfirst into the future by hooking their curriculum to...

Continue Reading
McCann Systems Scores Big with Dual AV Awards Wins

Updated Category News Views 1

Piling Up the Accolades: McCann Systems Does It Again You know, getting industry awards can sometimes feel like counting beans, but when a company's snagging them year after year, that’s worth noting. McCann Systems is strutting its stuff with two Commercial Integrator Awards in 2026, cementing their reputation not just here in New Jersey, but across the AV industry....

Continue Reading
Safety and Wellbeing as Key Business Strategy Focus

Updated Category News Views 1

Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...

Continue Reading
Alcatraz AI: A Silent Titan in Data Center Security

Updated Category News Views 0

Why Alcatraz AI is the Security of Choice Forget flashy press releases and splashy marketing campaigns. Alcatraz AI, a company operating out of the hustle and bustle of Cupertino, has managed to quietly dominate a key sector without many folks being the wiser. What's their claim to fame, you ask? They're the chosen gatekeepers for over half of the hyperscale data centers...

Continue Reading
APX Bridges Crypto & Traditional Finance With New Credit Line

Updated Category News Views 0

The Future of Financial Bridging Now here's a scenario that might perk your ears up if you've ever toyed with digital assets: APX Lending is stepping up its game, bringing a regulated five-year revolving line of credit backed by Bitcoin and Ethereum to the world stage. It's like blending your grandma's tried-and-true savings approach with the whiz-bang allure of crypto. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Japan's Mobile Phone Insurance Market Dynamics

Updated Category News Views 131

Japan's Expanding Mobile Phone Insurance Sector The mobile phone insurance market in Japan is on a remarkable growth path, set to exceed USD 9,934.20 million by 2032. Currently, the market is valued at USD 3,676.54 million and is projected to grow at a compound annual growth rate (CAGR) of 12.37% from 2024 to 2032. This trend highlights consumers' increasing awareness...

Continue Reading
Humanetics Develops Revolutionary Drug for Radiation Protection

Updated Category News Views 46

Humanetics Corporation's Commitment to Innovation Humanetics Corporation is significantly advancing its mission in the realm of medical countermeasures with the recent publication of critical findings from two studies centered around its innovative drug, BIO 300. This groundbreaking drug offers a promising approach to combat acute radiation syndrome (ARS), a condition...

Continue Reading
Rubis Announces New Leadership and Board Enhancements

Updated Category News Views 182

Rubis Announces New Leadership and Board Enhancements In a significant move to enhance its governance structure, Rubis has announced the proposal for the appointment of two new Managing Partners. This initiative reflects the company's commitment to ensuring a smooth succession as it prepares for the future. The appointments are under the supervision of the current...

Continue Reading
EQT Exeter Expands European Logistics Footprint with Acquisition

Updated Category News Views 88

EQT Exeter Expands European Logistics Footprint EQT Exeter, a prominent player in the global real estate investment sector, has recently made headlines with its exciting acquisition of four logistics properties in Germany. This strategic move demonstrates the company's commitment to expanding its portfolio in key distribution locations throughout Europe. Key Features of...

Continue Reading
Cleveland-Cliffs Inc. Faces Investigation Over Misleading Claims

Updated Category News Views 144

Understanding the Current Situation at Cleveland-Cliffs Inc. Cleveland-Cliffs Inc. (NYSE: CLF) is an important player in the steel industry, and recent developments have raised significant concern among its investors. This story unfolds as the Rosen Law Firm reveals ongoing investigations amid allegations that the company may have provided misleading business information,...

Continue Reading